Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Press

Showing results (91-100 of 272) with videos related to

Pageof 28
Sort By:
Current Opinion in Hematology|July 1, 1995
Targeted therapy for hematologic malignancies: has its promise been realized?D C Matthews, F R Appelbaum, O W Press, et al.
Physical Review Letters|December 31, 2005
Phonon modes at the 2H-NbSe2 surface observed by grazing incidence inelastic x-ray scatteringB M Murphy, H Requardt, J Stettner, et al.
Blood|August 15, 1992
Monoclonal antibody-based therapies of leukemia and lymphomaM L Grossbard, O W Press, F R Appelbaum, et al.
Cancer Research|September 1, 1989
Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignanciesO W Press, A G Farr, K I Borroz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 2, 2017
Pretargeting with bispecific fusion proteins facilitates delivery of nanoparticles to tumor cells with distinct surface antigensQi Yang, Christina L Parker, Yukang Lin, et al.
Molecular Pharmaceutics|March 10, 2017
Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic PeptidesHanna B Kern, Selvi Srinivasan, Anthony J Convertine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
New treatment options have changed the survival of patients with follicular lymphomaRichard I Fisher, Michael LeBlanc, Oliver W Press, et al.
Advanced Healthcare Materials|March 13, 2015
Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapyQingxin Mu, Mike Jeon, Meng-Hsuan Hsiao, et al.
Bioconjugate Chemistry|May 29, 1999
Hemolytic activity of pH-responsive polymer-streptavidin bioconjugatesC A Lackey, N Murthy, O W Press, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest doseJoseph G Rajendran, Ajay K Gopal, Darrel R Fisher, et al.
Pageof 28

Showing results (91-100 of 272) with videos related to

Sort By:
Pageof 28
Current Opinion in Hematology|July 1, 1995
Targeted therapy for hematologic malignancies: has its promise been realized?D C Matthews, F R Appelbaum, O W Press, et al.
Physical Review Letters|December 31, 2005
Phonon modes at the 2H-NbSe2 surface observed by grazing incidence inelastic x-ray scatteringB M Murphy, H Requardt, J Stettner, et al.
Blood|August 15, 1992
Monoclonal antibody-based therapies of leukemia and lymphomaM L Grossbard, O W Press, F R Appelbaum, et al.
Cancer Research|September 1, 1989
Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignanciesO W Press, A G Farr, K I Borroz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 2, 2017
Pretargeting with bispecific fusion proteins facilitates delivery of nanoparticles to tumor cells with distinct surface antigensQi Yang, Christina L Parker, Yukang Lin, et al.
Molecular Pharmaceutics|March 10, 2017
Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic PeptidesHanna B Kern, Selvi Srinivasan, Anthony J Convertine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
New treatment options have changed the survival of patients with follicular lymphomaRichard I Fisher, Michael LeBlanc, Oliver W Press, et al.
Advanced Healthcare Materials|March 13, 2015
Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapyQingxin Mu, Mike Jeon, Meng-Hsuan Hsiao, et al.
Bioconjugate Chemistry|May 29, 1999
Hemolytic activity of pH-responsive polymer-streptavidin bioconjugatesC A Lackey, N Murthy, O W Press, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest doseJoseph G Rajendran, Ajay K Gopal, Darrel R Fisher, et al.
Pageof 28